CCM
GDRX icon

Coldstream Capital Management’s GoodRx Holdings GDRX Stock Holding History

Coldstream Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40
Closed -$177 – 1957
2025
Q1 		$177 Buy
+40
New +$188 ﹤0.01% 3485

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Coldstream Capital Management's GDRX Position: Q2 2025 in Review

Coldstream Capital Management sold out of GoodRx Holdings (GDRX) in Q2 2025, closing a stake of 40 shares — an estimated $177 sold.

Coldstream Capital Management first reported a position in GDRX in Q1 2025 and held it in 1 quarter. The position peaked at $177 in Q1 2025. 182 funds tracked by Wall St. Rank hold GDRX as of Q2 2025.

  • Coldstream Capital Management reported no remaining GoodRx Holdings position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 40 GoodRx Holdings shares in Q2 2025, an estimated $177.
  • Coldstream Capital Management first reported a position in GoodRx Holdings in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's GoodRx Holdings position peaked at $177 in Q1 2025.
  • 182 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.